T2 Biosystems Announces Continued International Expansion into Taiwan with Exclusive Distribution Agreement

LEXINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of a territory exclusive distribution agreement in Taiwan.  

Click here to view original post